Francesca Romana Mauro

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (9)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Collaborators (9)

Marta COSCIA

Assistant Professor of Hematology

University of Turin

ITALY

View details

Stefano Molica

UNITED KINGDOM

View details

PAOLO SPORTOLETTI

Università degli Studi di Napoli Federico II

ITALY

View details

Adalgisa Condoluci

Institute of Cancer Research

SWITZERLAND

View details

Francesco Piazza

Assistant Professor of Hematology

Università degli Studi della Campania Luigi Vanvitelli Scuola di Medicina e Chirurgia

ITALY

View details

Candida VITALE

University of Turin

ITALY

View details

Andrea Visentin

Assistant professor

University of Padua

ITALY

View details

Livio Trentin

ITALY

View details

Francesco Angotzi

University of Padua

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Francesca Romana Mauro

Research Interests

Explore related searches

Contact this professor

Articles (9)

Continuous venetoclax in treatment‐naive <scp><i>TP</i>53</scp> disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study

Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter Study

The time to first treatment is an independent predictor of overall survival in chronic lymphocytic leukemia

Pre‐exposure prophylaxis with tixagevimab/cilgavimab in patients with chronic lymphocytic leukaemia treated with targeted agents

Efficacy of front‐line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter “Real‐World” study

Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three‐factor model

Early CD49d downmodulation in chronic lymphocytic leukemia patients treated front-line with ibrutinib plus rituximab predicts long-term response

Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real-life campus CLL study.

Redefining the prognostic likelihood of chronic lymphocytic leukaemia patients with borderline percentage of immunoglobulin variable heavy chain region mutations

Collaborators (9)

Marta COSCIA

Stefano Molica

PAOLO SPORTOLETTI

Adalgisa Condoluci

Francesco Piazza

Candida VITALE

Andrea Visentin

Livio Trentin

Francesco Angotzi

Make your next move.